إرسال التسجيلة بالبريد الالكتروني: Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

إلى:

رسالة: